Can complete blood counts and ratios be an adjunct to prostate specific antigen for avoiding unnecessary transrectal ultrasound-guided prostate biopsy?

Basit Öğe Kaydı
dc.contributor.authorAmasyali, Akin Soner
dc.contributor.authorKoç, Akif
dc.contributor.authorYıldırım, Mehmet Erol
dc.contributor.authorSarı, Erhan
dc.contributor.authorGüler, Cem
dc.contributor.authorErol, Haluk
dc.date.accessioned2025-10-24T18:06:46Z
dc.date.available2025-10-24T18:06:46Z
dc.date.issued2016
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractWe aimed to evaluate, if complete blood counts (CBC) evaluated before prostate biopsy could predict the result of the prostate biopsy performed due to the increased PSA levels. We retrospectively reviewed the data of 281 patients who had undergone prostate biopsy because of the increased levels of PSA in three university hospital. Patient’s age, pre-biopsy CBC, total PSA, free PSA, prostate volume and biopsy results were recorded. Patients were grouped according to the prostate biopsy results as; I: prostate cancer, II: Benign prostate hiperplasia, III: chronic prostatitis. We invastigated whether CBC counts and their ratios of this counts have any statistically significant predictive value in the three groups. A statistically significant difference was detected among the three groups regarding platelet count, neutrophil/monocyte (NMR) and platelet/lymphocyte ratios (PLR). The patelet count and PLRs were significantly higher in Group III rather than Groups I and II. Also the NMR was significantly higher in Group III than Group II. We have shown that pre-biopsy platelet count, NMR and PLR could predict thethe outcome of chronic prostatitis who had undergone prostate biopsy because of the increased levels of PSA. Furthermore, prospective case-controlled, large studies would be helpful to explore the predictive value of CBC on the prostate biopsy results. © 2021 Elsevier B.V., All rights reserved.
dc.identifier.doi10.5222/MMJ.2016.001
dc.identifier.endpage5
dc.identifier.issn2149-2042
dc.identifier.issn2149-4606
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85044124174
dc.identifier.scopusqualityQ2
dc.identifier.startpage1
dc.identifier.urihttps://doi.rog/10.5222/MMJ.2016.001
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3202
dc.identifier.volume31
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherLogos Medical Publishing
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzScopus_20251023
dc.subjectBenign prostate hyperplasia
dc.subjectChronic prostatitis
dc.subjectLeukocyte neutrophil
dc.subjectLymphocyte
dc.subjectProstate cancer
dc.titleCan complete blood counts and ratios be an adjunct to prostate specific antigen for avoiding unnecessary transrectal ultrasound-guided prostate biopsy?
dc.title.alternativeTam kan değerleri ve oranları gereksiz transrektal ultrasound prostat biyopsiyi önlemede prostat spesifik antijenine yardımcı parametre olabilir mi?
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu